See the impact of ENTYVIO (vedolizumab) in reducing symptoms and achieving remission for Crohn’s disease. See Safety and Prescribing Information.

Learn more about ENTYVIO® (vedolizumab), a biologic treatment for moderate to severe ulcerative colitis or Crohn's disease in adults.

Oct 30, 2024 · Learn more: Does Medicaid cover Entyvio? Related questions Why is Entyvio prescribed? Entyvio (vedolizumab) is approved by the FDA to treat ulcerative colitis (UC) or Crohn's …

May 11, 2023 · In this real-world comparative effectiveness study, we observe similar rates of clinical remission at 6 and 12 months after initiating first-line vedolizumab or ustekinumab therapy,” said Dr. …

Nov 24, 2025 · Abstract. Introduction: Vedolizumab (VDZ) has been available for Japanese patients with ulcerative colitis (UC). However, real-world data regarding the long-term efficacy and safety of VDZ …

Entyvio, also known by its generic name Vedolizumab, is a medical drug used to treat moderate to severe ulcerative colitis and Crohn’s disease in patients who don’t show improvement while on other …

How Was It Studied? The effect of Entyvio on disease remission was studied in people with moderate to severe ulcerative colitis and Crohn’s disease. People in these studies were between the ages ...

Entyvio (vedolizumab) has been approved by the U.S. Food and Drug Administration (FDA) for inducing and maintaining clinical response, inducing and maintaining clinical remission, improving endoscopic …

Oct 20, 2017 · The Entyvio Patient Assistance Program offers patients who qualify the opportunity to lower their vedolizumab cost. Prescription Hope provides access to the Entyvio Patient Assistance …

Dec 19, 2025 · Crohn's disease is a chronic inflammatory bowel disease that requires long-term medical and surgical management to improve quality of life.